(Q84037171)
English
Therapeutic effect of recombinant human epidermal growth factor (RhEGF) on mucositis in patients undergoing radiotherapy, with or without chemotherapy, for head and neck cancer: a double-blind placebo-controlled prospective phase 2 multi-institution
scientific article published on 01 August 2009
Statements
Therapeutic effect of recombinant human epidermal growth factor (RhEGF) on mucositis in patients undergoing radiotherapy, with or without chemotherapy, for head and neck cancer: a double-blind placebo-controlled prospective phase 2 multi-institutional clinical trial (English)
Hong Gyun Wu
Si Yeol Song
Yeon Sil Kim
Young Taek Oh
Chang Geol Lee
Ki Chang Keum
Yong Chan Ahn